12.1 CLINICAL PHARMACOLOGY-Mechanism of Action 12.2 CLINICAL PHARMACOLOGY-Pharmacodynamics 12.3 CLINICAL PHARMACOLOGY-Pharmacokinetics 12.4 CLINICAL PHARMACOLOGY-Microbiology 12.5 CLINICAL PHARMACOLOGY-Pharmacogenomics 13.1 NONCLINICAL TOXICOLOGY-Carcinogenesis-Mutagenesis- Impairment of Fertility 13.2 NONCLINICAL TOXICOLOGY-Animal Toxicology and Pharmacology 14 CLINICAL STUDIES 14.1 CLINICAL STUDIES-Healthy Adults 14.2 CLINICAL STUDIES-HIV-associated Enteropathy 14.3 CLINICAL STUDIES-IBS-D 14.4 CLINICAL STUDIES-Hypercholesterolemia 14.5 CLINICAL STUDIES-Pediatric Malnutrition 15 REFERENCES 16 HOW SUPPLIED-STORAGE AND HANDLING 17.1 PATIENT COUNSELING INFORMATION-Instructions for Use 17.2 PATIENT COUNSELING INFORMATION-Pregnancy and Nursing 17.3 PATIENT COUNSELING INFORMATION-Warnings and Precautions
1.1 INDICATIONS AND USAGE-Impaired Nutrient Absorption 1.2 INDICATIONS AND USAGE-Chronic Loose or Frequent Stools 1.3 INDICATION AND USAGE-HIV-associated Enteropathy 2.1 DOSAGE AND ADMINISTRATION-Recommended Dosing 2.2 DOSAGE AND ADMINISTRATION-Pediatric Patients 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 5 WARNINGS AND PRECAUTIONS 6.1 ADVERSE REACTIONS-Clinical Trial Experience 6.2 ADVERSE REACTIONS-Post-marketing surveillance 7 DRUG INTERACTIONS 8.1 USE IN SPECIFIC POPULATIONS-Pregnancy 8.2 USE IN SPECIFIC POPULATIONS-Labor and Delivery 8.3 USE IN SPECIFIC POPULATIONS-Nursing Mothers 8.4 USE IN SPECIFIC POPULATIONS-Pediatric Use 8.5 USE IN SPECIFIC POPULATIONS-Geriatric Use 10 OVERDOSAGE 11 DESCRIPTION